Search Results

Aylin Hanyaloglu, Caroline Gorvin, and Alejandra Tomas.

Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling Abigail Walker, Aylin Hanyaloglu, et al., for their study on Constitutive internalisation of EP2 differentially regulates

Meanwhile, incretin and amylin-based therapies are reshaping the obesity drug landscape. Eli Lilly’s next moves with Orforglipron and its amylin analog are highly anticipated.  

Aylin Hanyaloglu Strategic Partners Dr. GPCR Podcast << Back to podcast list Dr. Aylin Hanyaloglu About Dr. Aylin Hanyaloglu Dr. Aylin Hanyaloglu has been a Principal Investigator at Imperial College London since 2007. Hanyaloglu undertook her postdoctoral training at the University of California, San Francisco with Professor Aylin Hanyaloglu on the web LinkedIn Researchgate Twitter Imperial College London Elsevier Loop Dr.

Aylin Hanyaloglu Dr. Aylin Hanyaloglu has been a Principal Investigator at Imperial College London since 2007. Hanyaloglu undertook her postdoctoral training at the University of California, San Francisco with Professor Aylin Hanyaloglu on the web LinkedIn Endocrine Metabolic GPCRs Researchgate Twitter Imperial College

investigated regulatory mechanisms of GPCR action, namely dimerization and membrane trafficking, in Dr Aylin Hanyaloglu 's lab at Imperial College London. currently funded by a postdoctoral fellowship from Wellcome Trust, working on a collaborative project (Dr Hanyaloglu's